Skip to main content

Table 1 The body weights, serum alanine aminotransferase (ALT), alkaline phosphatase (ALP) aspartate aminotransferase (AST), creatinine and urea levels before and after treatment

From: Biochemical characterization and 1H NMR based metabolomics revealed Melicope lunu-ankenda leaf extract a potent anti-diabetic agent in rats

 

Before treatment

After treatment

 

NG

DG

MG

LDG

HDG

NG

DG

MG

LDG

HDG

ALT(U/L)

37.0 ± 2.0b

54.4 ± 2.9a

52.8 ± 3.1a

51.5 ± 3.6a

55.1 ± 3.9 a

34.3 ± 3.0c

64.5 ± 4.6a*

37.4 ± 3.1c*

55.2 ± 5.0b

39.3 ± 3.7c*

ALP (U/L)

61.0 ± 6.8b

159.3 ± 9.0a

160.8 ± 9.2a

161.00 ± 6.9a

158.5 ± 4.5a

63.6 ± 6.7c

165.0 ± 13.9a

70.8 ± 6.1c*

111.2 ± 8.7b*

76.4 ± 6.3c*

AST(U/L)

79.0 ± 3.3a

90.1 ± 6.7a

89.7 ± 5.9a

88.7 ± 5.3a

89.8 ± 6.3a

82.4 ± 2.8c

101.4 ± 10.2a*

85.6 ± 5.2bc

92.6 ± 6.5b

84.3 ± 2.4bc

Creatinine (umol/L)

53.5 ± 3.8b

61.3 ± 3.2a

57.3 ± 2.3ab

59.3 ± 3.6ab

58.3 ± 4.2ab

62.3 ± 7.3b

70.8 ± 7.1a*

64.8 ± 4.1ab

66.5 ± 4.0ab

62.5 ± 6.0ab

Urea (mmol/L)

6.4 ± 0.2a

6.7 ± 0.2a

6.9 ± 0.7a

6.7 ± 0.9a

6.8 ± 0.8a

6.1 ± 0.93b

12.5 ± 2.0a*

6.6 ± 0.4b

10.6 ± 0.9a*

7.0 ± 0.9b

  1. ND Normal diet, DG diabetic group, MG metformin group, LDG low dose group, HDG high dose group. Significance difference (p < 0.05) among different groups within same period of treatment is shown by different letters, whereas * shows significance (p < 0.05) difference within same group at different period of treatment